| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 152286-31-2 | TYR-GLU-VAL-HIS-His-Gln-LYS-LEU-VAL-PHE-PHE | H-TYR-GLU-VAL-HIS-His-Gln-LYS-LEU-VAL-PHE-PHE-OH; AMYLOID BETA-PROTEIN (10-20); AMYLOID BETA-PEPTIDE (10-20) (HUMAN); AMYLOID BETA-PROTEIN FRAGMENT 10-20; H-TYR-GLU-VAL-HIS-His-Gln-LYS-LEU-VAL-PHE-PHE-OH; BETA-AMYLOID (10-20); YEVHHQKLVFF; TYR-GLU-VAL-HIS-His-Gln-LYS-LEU-VAL-PHE-PHE; amyloid B-protein fragment 10-20 |  | C71H99N17O16 | 詳情 | 供應商 |
| 107015-83-8 | 淀粉-Β-蛋白片段12-28 | H-VAL-HIS-His-Gln-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-OH; H-VAL-HIS-His-Gln-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-OH; BETA-AMYLOID (12-28); BETA-AMYLOID PEPTIDE [12-28], HUMAN; ALZHEIMER'S DISEASE BETA-PROTEIN (12-28); AMYLOID, BETA- (12-28), HUMAN; AMYLOID BETA-PROTEIN (12-28); AMYLOID-BETA PROTEIN (12-28), HUMAN; AMYLOID BETA-PROTEIN FRAGMENT 12-28 |  | C89H135N25O25 | 詳情 | 供應商 |
| 166090-74-0 | H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH | H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-His-Gln-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GL; PREDOMINANT AMYLOID B-PROTEIN FRAGMENT; ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-His-Gln-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA; ASP-ALA-GLU-PHE-GLY-HIS-ASP-SER-GLY-PHE-GLU-VAL-ARG-His-Gln-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA; BAP 1-42; BETA-AMYLOID, SODIUM SALT; BETA-AMYLOID PEPTIDE (1-40), MOUSE, RAT; BETA-AMYLOID PEPTIDE (1-40), RAT; BETA-AMYLOID PEPTIDE (1-42), RAT | 無 | C203H311N55O60S | 詳情 | 供應商 |
| 313951-59-6 | (DES-OCTANOYL)-GHRELIN (HUMAN) | H-GLY-SER-SER-PHE-LEU-SER-PRO-GLU-His-Gln-ARG-VAL-GLN-GLN-ARG-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-LE; GSSFLSPEHQRVQQRKESKKPPAKLQPR; GLY-SER-SER-PHE-LEU-SER-PRO-GLU-His-Gln-ARG-VAL-GLN-GLN-ARG-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-LEU-GLN-PRO-ARG; H-GLY-SER-SER-PHE-LEU-SER-PRO-GLU-His-Gln-ARG-VAL-GLN-GLN-ARG-LYS-GLU-SER-LYS-LYS-PRO-PRO-ALA-LYS-LEU-GLN-PRO-ARG-OH; (DES-OCTANOYL)-GHRELIN (HUMAN); H-Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH; M.W. 3244.51 C141H235N47O41 |  | C141H235N47O41 | 詳情 | 供應商 |
| 126738-34-9 | CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-LEU-ASN-PHE-CYS-His-Gln-ASP-VAL-ILE-TRP (DISULFIDE BRIDG | H-CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-LEU-ASN-PHE-CYS-His-Gln-ASP-VAL-ILE-TRP-OH; SARAFOTOXIN A; SARAFOTOXIN A (ATRACTASPIS ENGADDENSIS); SARAFOTOXIN S6A; SARAFOTOXIN S6A1; SARAFOTOXIN S6A (ATRACTASPIS ENGADDENSIS); H-CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-LEU-ASN-PHE-CYS-His-Gln-ASP-VAL-ILE-TRP-OH; CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-LEU-ASN-PHE-CYS-His-Gln-ASP-VAL-ILE-TRP; M.W. 2514.85 C105H156N28O34S5 |  | C105H156N28O34S5 | 詳情 | 供應商 |
| 112955-31-4 | ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS- | ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-; PTH-RP (HUMAN, 1-34 AMIDE) (RAT, MOUSE); PARATHYROID HORMONE RELATED PROTEIN (HUMAN, 1-34 AMIDE) (RAT, MOUSE); ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2; HYPERCALCEMIA OF MALIGNANCY FACTOR*FRAGM ENT 1-34 AM; ala-val-ser-glu-His-Gln-leu-leu-his-asp-lys-gly-lys-ser-ile-gln-asp-leu-arg-arg-arg-phe-phe-leu-his-his-leu-ile-ala-glu-ile-his-thr-ala-nh2; Parathyroid hormone-related protein (1-34) Amide, PTHrP (1-34) amide, Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2; Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human) | 無 | C180H288N58O47 | 詳情 | 供應商 |
| 133605-53-5 | ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLN-VAL-HIS-His-Gln-LYS | H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLN-VAL-HIS-His-Gln-LYS-OH; ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-His-Gln-LYS; ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLN-VAL-HIS-His-Gln-LYS; DAEFRHDSGYQVHHQK; H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLN-VAL-HIS-His-Gln-LYS-OH; [GLN11] AMYLOID BETA-PROTEIN (1-16); [GLN11]-BETA-AMYLOID (1-16); AMYLOID BETA-PROTEIN [GLN11]-FRAGMENT 1-16; AMYLOID BETA-PROTEIN (HUMAN, 1-16) |  | C84H120N28O27 | 詳情 | 供應商 |
| 112540-82-6 | ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-His-Gln-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 無 | C180H287N57O48 | 詳情 | 供應商 |